Auro Laboratories [AUROLAB] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Auro Laboratories Limited

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Auro Laboratories Limited wins in 10 metrics, Gujarat Themis Biosyn Ltd. wins in 9 metrics, with 0 ties. Auro Laboratories Limited appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Auro Laboratories Limited Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) 48.08 73.73 Auro Laboratories Limited
Price-to-Book Ratio 3.57 13.36 Auro Laboratories Limited
Debt-to-Equity Ratio 100.84 27.04 Gujarat Themis Biosyn Ltd.
PEG Ratio 0.01 -17.55 Auro Laboratories Limited
EV/EBITDA 31.14 52.76 Auro Laboratories Limited
Profit Margin (TTM) 11.39% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) 32.83% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) 32.83% 40.16% Gujarat Themis Biosyn Ltd.
Return on Equity 4.28% 19.64% Gujarat Themis Biosyn Ltd.
Return on Assets (TTM) 1.86% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $-180.54M $-251.22M Auro Laboratories Limited
Dividend Yield N/A 0.17% N/A
1-Year Return 11.96% 31.69% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 5.48 22.23 Auro Laboratories Limited
Enterprise Value $2.03B $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 7.13 22.65 Auro Laboratories Limited
Gross Profit Margin (TTM) 88.05% 83.29% Auro Laboratories Limited
Revenue per Share (TTM) $46 $15 Auro Laboratories Limited
Earnings per Share (Diluted) $5.20 $4.40 Auro Laboratories Limited
Beta (Stock Volatility) 0.09 -0.17 Gujarat Themis Biosyn Ltd.

Auro Laboratories Limited vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

AUROLAB
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Auro Laboratories Limited-1.52%-3.45%6.14%-8.81%2.74%7.86%
Gujarat Themis Biosyn Ltd.1.72%-7.03%7.92%39.85%0.71%-8.80%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Auro Laboratories Limited11.96%219.81%161.67%1,083.37%3,551.32%4,900.00%
Gujarat Themis Biosyn Ltd.31.69%84.69%84.69%84.69%84.69%84.69%

Performance & Financial Health Analysis: Auro Laboratories Limited vs Gujarat Themis Biosyn Ltd.

MetricAUROLABGUJTHEM
Market Information
Market Cap i₹1.56B₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4,55779,452
90 Day Avg. Volume i4,543106,446
Last Close₹262.90₹401.80
52 Week Range₹159.00 - ₹317.00₹225.05 - ₹479.00
% from 52W High-17.07%-16.12%
All-Time High₹317.00 (Feb 18, 2026)₹479.00 (Oct 27, 2025)
% from All-Time High-17.07%-16.12%
Growth Metrics
Quarterly Revenue Growth2.08%0.10%
Quarterly Earnings Growth37.27%-0.04%
Financial Health
Profit Margin (TTM) i0.11%0.30%
Operating Margin (TTM) i0.33%0.40%
Return on Equity (TTM) i0.04%0.20%
Debt to Equity (MRQ) i100.8427.04
Cash & Liquidity
Book Value per Share (MRQ)₹70.01₹24.29
Cash per Share (MRQ)₹1.07₹0.92
Operating Cash Flow (TTM) i₹74.16M₹970.68M
Levered Free Cash Flow (TTM) i₹18.39M₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend iN/A₹0.67

Valuation & Enterprise Metrics Analysis: Auro Laboratories Limited vs Gujarat Themis Biosyn Ltd.

MetricAUROLAB (Apr 26, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i48.0873.73
Forward P/E iN/AN/A
PEG Ratio i0.01-17.55
Price to Sales (TTM) i5.4822.23
Price to Book (MRQ) i3.5713.36
Market Capitalization
Market Capitalization i₹1.56B₹35.41B
Enterprise Value i₹2.03B₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i7.1322.65
Enterprise to EBITDA i31.1452.76
Risk & Other Metrics
Beta i0.09-0.17
Book Value per Share (MRQ) i₹70.01₹24.29

Financial Statements Comparison: Auro Laboratories Limited vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAUROLAB (2025)GUJTHEM (2025)
Revenue/Sales i191.24M1.51B
Cost of Goods Sold i99.08M318.78M
COGS % of Revenue i51.8%21.1%
Gross Profit i92.16M1.19B
Gross Margin i48.2%78.9%
Research & Development iN/A34.37M
Operating Income (EBIT) i23.07M642.49M
Operating Margin i12.1%42.6%
EBITDA i40.60M713.04M
EBITDA Margin i21.2%47.3%
Pre-Tax Income i18.81M655.38M
Pre-Tax Income % of Revenue i9.8%43.5%
Income Tax i421,000167.66M
Income Tax % of Revenue i0.2%11.1%
Net Income (Profit) i18.39M487.72M
Profit Margin i9.6%32.3%

Balance Sheet & Liquidity Metrics

MetricAUROLAB (2025)GUJTHEM (2025)
Cash & Equivalents i3,000116.94M
Total Current Assets i215.14M519.73M
Total Current Assets % of Revenue i112.5%34.5%
Total Current Liabilities i216.42M205.60M
Total Current Liabilities % of Revenue i113.2%13.6%
Long-Term Debt i330.85M296.36M
Long-Term Debt % of Revenue i173.0%19.7%
Total Shareholders Equity i429.68M2.48B
Retained Earnings i359.52M2.37B
Retained Earnings % of Revenue i188.0%157.4%
Property, Plant & Equipment i16.55M411.30M

Cash Flow Statement Comparison

MetricAUROLAB (2025)GUJTHEM (2025)
Operating Cash Flow i74.16M970.68M
Operating Cash Flow % of Revenue i38.8%64.4%
Capital Expenditures i20,000-1.16B
Free Cash Flow i-180.54M-251.22M
FCF Margin i-94.4%-16.7%
Debt Repayment i0N/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAUROLABGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i6.23M108.97M
Float Shares i2.35M29.52M
% Held by Insiders i60.96%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i39.04%26.84%

Dividend Analysis & Yield Comparison: Auro Laboratories Limited vs Gujarat Themis Biosyn Ltd.

MetricAUROLABGUJTHEM
Last 12-Month Dividend iN/A₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend iN/A₹0.22
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends iN/A₹0.67
Ex-Dividend DateN/ASep 04, 2025